These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Determination of 2-methoxyestradiol in human plasma, using liquid chromatography/tandem mass spectrometry. Lakhani NJ; Lepper ER; Sparreboom A; Dahut WL; Venitz J; Figg WD Rapid Commun Mass Spectrom; 2005; 19(9):1176-82. PubMed ID: 15818726 [TBL] [Abstract][Full Text] [Related]
5. Flutamide metabolism in four different species in vitro and identification of flutamide metabolites in human patient urine by high performance liquid chromatography/tandem mass spectrometry. Tevell A; Lennernäs H; Jönsson M; Norlin M; Lennernäs B; Bondesson U; Hedeland M Drug Metab Dispos; 2006 Jun; 34(6):984-92. PubMed ID: 16540588 [TBL] [Abstract][Full Text] [Related]
6. Metabolism of prazosin in rat, dog, and human liver microsomes and cryopreserved rat and human hepatocytes and characterization of metabolites by liquid chromatography/tandem mass spectrometry. Erve JC; Vashishtha SC; DeMaio W; Talaat RE Drug Metab Dispos; 2007 Jun; 35(6):908-16. PubMed ID: 17353349 [TBL] [Abstract][Full Text] [Related]
7. Characterization of the metabolism of sibiricaxanthone F and its aglycone in vitro by high performance liquid chromatography coupled with Q-trap mass spectrometry. Song Y; Yang X; Jiang Y; Tu P J Pharm Biomed Anal; 2012 Nov; 70():700-7. PubMed ID: 22819207 [TBL] [Abstract][Full Text] [Related]
8. Metabolism, distribution and excretion of a selective N-methyl-D-aspartate receptor antagonist, traxoprodil, in rats and dogs. Prakash C; Cui D; Potchoiba MJ; Butler T Drug Metab Dispos; 2007 Aug; 35(8):1350-64. PubMed ID: 17496205 [TBL] [Abstract][Full Text] [Related]
9. Metabolism and excretion of RWJ-333369 [1,2-ethanediol, 1-(2-chlorophenyl)-, 2-carbamate, (S)-] in mice, rats, rabbits, and dogs. Mamidi RN; Mannens G; Annaert P; Hendrickx J; Goris I; Bockx M; Janssen CG; Kao M; Kelley MF; Meuldermans W Drug Metab Dispos; 2007 Apr; 35(4):566-75. PubMed ID: 17220243 [TBL] [Abstract][Full Text] [Related]
10. The absorption, metabolism, and excretion of the novel neuromodulator RWJ-333369 (1,2-ethanediol, [1-2-chlorophenyl]-, 2-carbamate, [S]-) in humans. Mannens GS; Hendrickx J; Janssen CG; Chien S; Van Hoof B; Verhaeghe T; Kao M; Kelley MF; Goris I; Bockx M; Verreet B; Bialer M; Meuldermans W Drug Metab Dispos; 2007 Apr; 35(4):554-65. PubMed ID: 16936066 [TBL] [Abstract][Full Text] [Related]
11. Regiospecific and stereospecific triangulation of the structures of metabolites formed by sequential metabolism at multiple prochiral centers. Greene RJ; Davis JA; Subramanian R; Deane MR; Emery MG; Slatter JG Drug Metab Dispos; 2012 May; 40(5):928-42. PubMed ID: 22328582 [TBL] [Abstract][Full Text] [Related]
12. Route of metabolization and detoxication of paralytic shellfish toxins in humans. García C; Barriga A; Díaz JC; Lagos M; Lagos N Toxicon; 2010 Jan; 55(1):135-44. PubMed ID: 19632259 [TBL] [Abstract][Full Text] [Related]
13. Glucuronidation of edaravone by human liver and kidney microsomes: biphasic kinetics and identification of UGT1A9 as the major UDP-glucuronosyltransferase isoform. Ma L; Sun J; Peng Y; Zhang R; Shao F; Hu X; Zhu J; Wang X; Cheng X; Zhu Y; Wan P; Feng D; Wu H; Wang G Drug Metab Dispos; 2012 Apr; 40(4):734-41. PubMed ID: 22238289 [TBL] [Abstract][Full Text] [Related]
14. Metabolism, pharmacokinetics, and excretion of the 5-hydroxytryptamine1b receptor antagonist elzasonan in humans. Kamel A; Obach RS; Colizza K; Wang W; O'Connell TN; Coelho RV; Kelley RM; Schildknegt K Drug Metab Dispos; 2010 Nov; 38(11):1984-99. PubMed ID: 20668248 [TBL] [Abstract][Full Text] [Related]
15. Radiosensitization and modulation of p44/42 mitogen-activated protein kinase by 2-Methoxyestradiol in prostate cancer models. Casarez EV; Dunlap-Brown ME; Conaway MR; Amorino GP Cancer Res; 2007 Sep; 67(17):8316-24. PubMed ID: 17804747 [TBL] [Abstract][Full Text] [Related]
16. Phase I clinical trial of oral 2-methoxyestradiol, an antiangiogenic and apoptotic agent, in patients with solid tumors. Dahut WL; Lakhani NJ; Gulley JL; Arlen PM; Kohn EC; Kotz H; McNally D; Parr A; Nguyen D; Yang SX; Steinberg SM; Venitz J; Sparreboom A; Figg WD Cancer Biol Ther; 2006 Jan; 5(1):22-7. PubMed ID: 16357512 [TBL] [Abstract][Full Text] [Related]
17. Metabolic characterization of (±)-praeruptorin A in vitro and in vivo by high performance liquid chromatography coupled with hybrid triple quadrupole-linear ion trap mass spectrometry and time-of-flight mass spectrometry. Song YL; Jing WH; Yan R; Wang YT J Pharm Biomed Anal; 2014 Mar; 90():98-110. PubMed ID: 24342524 [TBL] [Abstract][Full Text] [Related]
18. Metabolism, pharmacokinetics, and excretion of the substance P receptor antagonist CP-122,721 in humans: structural characterization of the novel major circulating metabolite 5-trifluoromethoxy salicylic acid by high-performance liquid chromatography-tandem mass spectrometry and NMR spectroscopy. Colizza K; Awad M; Kamel A Drug Metab Dispos; 2007 Jun; 35(6):884-97. PubMed ID: 17360832 [TBL] [Abstract][Full Text] [Related]
19. Identification of in vivo and in vitro metabolites of triptolide by liquid chromatography-tandem mass spectrometry. Peng ZH; Wang JJ; Du P; Chen Y J Pharm Biomed Anal; 2012 Nov; 70():624-30. PubMed ID: 22824635 [TBL] [Abstract][Full Text] [Related]
20. Recent Advances in chemistry and pharmacology of 2-methoxyestradiol: An anticancer investigational drug. Kumar BS; Raghuvanshi DS; Hasanain M; Alam S; Sarkar J; Mitra K; Khan F; Negi AS Steroids; 2016 Jun; 110():9-34. PubMed ID: 27020471 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]